View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
March 1, 2022

Magazine: Cutting the carbon footprint of pharma’s supply chain

In this issue: We examine the supply chain for delivering Covid-19 antivirals, and the pharma industry's quest to decarbonise.

By Manasi Vaidya

The latest issue of Pharma Technology Focus is out now. Read it for free on all devices.

More than two years into the pandemic, maintaining a reliable supply chain continues to be a priority for governments and industrial sectors, and any inefficiencies consequently touch people’s lives in one way or another.

In this issue, we took a hard look at the pharmaceutical supply chain by exploring its environmental impact and what happens when it does not work as well as it should. While several pharma companies have pledged to reduce their carbon footprint, they can achieve those goals only if every stakeholder in the process works to make the necessary changes.

The supply and delivery of Covid-19 therapeutics in the US, especially during the surge of cases due to the Omicron variant, provide a great example of how distribution gaps are sometimes exacerbated. In two data-led pieces, we try to correlate the per capita allocations, state populations and Covid-19 case rates to identify places that had the most acute shortages, where better supply planning could have addressed the surge of cases.

Also in this issue, we took a look at the growing research with psychedelics in biotech, both from a research and manufacturing perspective.

Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a new issue is available.

Related Companies

Free Whitepaper

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy